Skip to main content

Advertisement

Log in

The impact of percutaneous coronary intervention using the novel dynamic coronary roadmap system

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

The dynamic coronary roadmap (DCR) is a novel technology that creates a dynamic, motion-compensated, real-time overlay of the coronary arteries on a fluoroscopic image. Whether the DCR reduces contrast volume and enables safe and effective treatment was examined. A total of 146 patients undergoing percutaneous coronary intervention (PCI) from June 2017 to September 2017 in our hospital were retrospectively evaluated. Chronic total occlusion lesions, acute coronary syndrome, and hemodialysis patients were excluded. Patients were divided into the control group (PCI without DCR, 92 patients, 103 lesions) and the DCR group (38 patients, 43 lesions). The primary endpoint was contrast medium volume, and secondary endpoints were radiation dose, fluoroscopy time, and clinical success rate. There was no significant difference in the success rate (100% vs. 100%, P = 1.000) between the groups. Fluoroscopy time (16.3 ± 11.2 min. vs. 11.4 ± 5.5 min, P = 0.007) and contrast medium volume (152.1 ± 73.0 ml vs. 118.8 ± 49.7 ml, P = 0.006) were significantly lower in the DCR group than in the control group. DCR use during PCI was associated with a significant reduction in contrast volume and fluoroscopy time compared to a control group despite similar clinical, lesion, and procedural characteristics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

DCR:

Dynamic coronary roadmap

PCI:

Percutaneous coronary intervention

References

  1. Navarese EP, Schulze V, Andreotti F, Kowalewski M, Kolodziejczak M, Kandzari DE, Rassaf T, Gorny B, Brockmeyer M, Meyer C, Berti S, Kubica J, Kelm M, Valgimigli M (2015) Comprehensive meta-analysis of safety and efficacy of bivalirudin versus heparin with or without routine glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndrome. JACC Cardiovasc Interv 8:201–213

    Article  Google Scholar 

  2. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR Jr (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259–2264

    Article  Google Scholar 

  3. Gupta R, Gurm HS, Bhatt DL, Chew DP, Ellis SG (2005) Renal failure after percutaneous coronary intervention is associated with high mortality. Catheter Cardiovasc Interv 64:442–448

    Article  Google Scholar 

  4. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, Farid N, McManamon PJ (1989) Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 320:143–149

    Article  CAS  Google Scholar 

  5. Goldenberg I, Chonchol M, Guetta V (2009) Reversible acute kidney injury following contrast exposure and the risk of long-term mortality. Am J Nephrol 29:136–144

    Article  Google Scholar 

  6. Trivedi HS, Moore H, Nasr S, Aggarwal K, Agrawal A, Goel P, Hewett J (2003) A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 93:C29–34

    Article  CAS  Google Scholar 

  7. Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SE, Pepine CJ, Watson RM, Ritchie JL, Gibbons RJ, Cheitlin MD, Gardner TJ, Garson A Jr, Russell RO Jr, Ryan TJ, Smith SC Jr (1999) ACC/AHA guidelines for coronary angiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions. Circulation 99:2345–2357

    Article  CAS  Google Scholar 

  8. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB III, Loop FD, Peterson KL, Reeves TJ, Williams DO, Winters WL Jr (1988) Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation 78:486–502

    Article  CAS  Google Scholar 

  9. Abaci O, Harmankaya O, Kocas B, Kocas C, Bostan C, Coskun U, Yildiz A, Ersanli M (2015) Long-term follow-up of patients at high risk for nephropathy after contrast exposure. Angiology 66:514–518

    Article  CAS  Google Scholar 

  10. Shiragami K, Fujii Z, Sakumura T, Shibuya M, Takahashi N, Yano M, Fujii T, Matsuzaki M (2008) Effect of a contrast agent on long-term renal function and the efficacy of prophylactic hemodiafiltration. Circ J 72:427–433

    Article  CAS  Google Scholar 

  11. Tepel M, Aspelin P, Lameire N (2006) Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation 113:1799–1806

    Article  Google Scholar 

  12. Lasser EC, Lyon SG, Berry CC (1997) Reports on contrast media reactions: analysis of data from reports to the US Food and Drug Administration. Radiology 203:605–610

    Article  CAS  Google Scholar 

  13. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ (2003) Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348:491–499

    Article  CAS  Google Scholar 

  14. Mariani J Jr, Guedes C, Soares P, Zalc S, Campos CM, Lopes AC, Spadaro AG, Perin MA, Filho AE, Takimura CK, Ribeiro E, Kalil-Filho R, Edelman ER, Serruys PW, Lemos PA (2014) Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial. JACC Cardiovasc Interv 7:1287–1293

    Article  Google Scholar 

  15. Ali ZA, Karimi Galougahi K, Nazif T, Maehara A, Hardy MA, Cohen DJ, Ratner LE, Collins MB, Moses JW, Kirtane AJ, Stone GW, Karmpaliotis D, Leon MB (2016) Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study. Eur Heart J 37:3090–3095

    Article  Google Scholar 

  16. Mukai Y, Sakakura K, Yamamoto K, Taniguchi Y, Tsukui T, Seguchi M, Wada H, Momomura SI, Fujita H (2019) Association of less-contrast media with clinical factors in elective percutaneous coronary intervention. Heart Vessels. https://doi.org/10.1007/s00380-019-01473-3

    Article  PubMed  Google Scholar 

  17. Karimi Galougahi K, Zalewski A, Leon MB, Karmpaliotis D, Ali ZA (2016) Optical coherence tomography-guided percutaneous coronary intervention in pre-terminal chronic kidney disease with no radio-contrast administration. Eur Heart J 37:1059

    Article  Google Scholar 

  18. Azzalini L, Mitomo S, Hachinohe D, Regazzoli D, Colombo A (2018) Zero-contrast percutaneous coronary intervention guided by dextran-based optical coherence tomography. Can J Cardiol 34:342.e1–342.e3

    Article  Google Scholar 

  19. Brown JR, Robb JF, Block CA, Schoolwerth AC, Kaplan AV, O'Connor GT, Solomon RJ, Malenka DJ (2010) Does safe dosing of iodinated contrast prevent contrast-induced acute kidney injury? Circ Cardiovasc Interv 3:346–350

    Article  Google Scholar 

  20. Gurm HS, Dixon SR, Smith DE, Share D, Lalonde T, Greenbaum A, Moscucci M (2011) Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 58:907–914

    Article  Google Scholar 

  21. Gurm HS, Seth M, Dixon SR, Michael Grossman P, Sukul D, Lalonde T, Cannon L, West D, Madder RD, Adam Lauver D (2019) Contemporary use of and outcomes associated with ultra-low contrast volume in patients undergoing percutaneous coronary interventions. Catheter Cardiovasc Interv 93:222–230

    Article  Google Scholar 

  22. Piayda K, Kleinebrecht L, Afzal S, Bullens R, Ter Horst I, Polzin A, Veulemans V, Dannenberg L, Wimmer AC, Jung C, Bonner F, Kelm M, Hellhammer K, Zeus T (2018) Dynamic coronary roadmapping during percutaneous coronary intervention: a feasibility study. Eur J Med Res 23:36

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takayuki Yabe.

Ethics declarations

Conflict of interest

All authors have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yabe, T., Muramatsu, T., Tsukahara, R. et al. The impact of percutaneous coronary intervention using the novel dynamic coronary roadmap system. Heart Vessels 35, 323–330 (2020). https://doi.org/10.1007/s00380-019-01502-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-019-01502-1

Keywords

Navigation